Jericho Assisted Living
Friday, December 9, 2016
U.S. Study: 'Risk Creep' For TAVR Began Before FDA Approval (CME/CE)
(MedPage Today) -- Mitral repair also on slow climb, per TVT Registry
via
U.S. Study: 'Risk Creep' For TAVR Began Before FDA Approval (CME/CE)
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment